Search results
Researchers take step toward development of universal COVID-19 antibodies
KTBS Shreveport· 4 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists ...
Scientists are testing mRNA vaccines to protect cows and people against bird flu
Associated Press via Yahoo News· 3 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA...
Study examines surge in RSV cases after the COVID-19 pandemic
Medical Xpress· 4 days agoThe surge in RSV cases following the COVID-19 pandemic may have been, in part, caused by increased testing and changes to the RSV genome, according to a ...
BioNTech pays $25M upfront to strengthen ADC bond with China's MediLink
FierceBiotech· 6 days agoAfter penning a couple of antibody-drug conjugate (ADC) deals in 2023, BioNTech has returned to MediLink Therapeutics to further pad out its portfolio. This...the German biotech ...
Levels of COVID in Mass. wastewater tick up with arrival of new ‘FLiRT’ variants - The Boston Globe
The Boston Globe· 5 days agoDoron called the increase “very, very, very gradual.” “Certainly it’s nothing like when Omicron was...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 4 days agoIn this study, Oncocyte’s proprietary diagnostic test using droplet-digital PCR was able to identify responders and non-responders to felzartamab, showing...decrease in dd-cfDNA ...
First Patient Gets mRNA Bowel Cancer Vaccine In England, With Thousands More Coming
IFLScience· 3 days agoThere’s great news today for cancer patients in England, as thousands are set to be fast-tracked...
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development...
Morningstar· 6 days agoTÜBINGEN, GERMANY AND BOSTON, MA / ACCESSWIRE / May 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based ...
Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
Medscape· 7 days agoNew trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.
Trying to solve the ‘cruel mystery,’ lupus
Post-Bulletin· 3 days agoWhile pregnant with her second child, Shamiere Schwahn noticed something was off. The symptoms she experienced, Schwahn said, were assumed to be because...